Meglumine antimoniate is a antimony derivative used to treat visceral, cutaneous and mucosal leishmaniasis.
EML status history
First added in 1987 (TRS 770) for Visceral leishmaniasis
Added in 1987 (TRS 770) for Mucocutaneous leishmaniasis
Added in 1987 (TRS 770) for Cutaneous leishmaniasis
- Parenteral > General injections > IM: 30% in 5 mL ampoule equivalent to approximately 8.1% antimony